Clinical Study

Sex, Diastolic Blood Pressure, and Outcome after Thrombolysis for Ischemic Stroke

Table 1

Baseline characteristics.

Total ()Men ()Women () value

Age71 (63–71)69 (61–76) 76 (67–84)<0.0001
Medical history
 Atrial fibrillation73 (20.6)29 (15)44 (27.2)0.005
 Diabetes 51 (14.4)23 (11.9)28 (17.3)0.2
 Smoke currently77 (21.7)43 (23.4)34 (22.5)0.89
 BMI26 ± 4.426 ± 4.026 ± 13.00.9
 Hypertension168 (47.3)80 (41.5)88 (54.3)0.02
Clinical assessment
 Baseline NIHSS score5 (3–11)5 (3–9)7 (3–14)0.006
 Systolic BP, mmHg152 ± 20152 ± 20152 ± 200.9
 Diastolic BP, mmHg81 ± 1384 ± 1378 ± 12<0.0001
 Diastolic BP >90 mmHg78 (22)55 (28.5)23 (14.2)0.001
 MAP, mmHg104 ± 13107 ± 13102 ± 120.002
Laboratory findings
 Glucose at admission, mmol/L7.0 ± 2.47.1 ± 2.76.8 ± 2.70.18
 Triglycerides, mmol/L1.4 ± 0.91.4 ± 0.81.4 ± 1.00.8
 LDL-cholesterol, mmol/L3.1 ± 1.03.1 ± 1.03.0 ± 0.90.4
 HDL-cholesterol, mmol/L1.4 ± 0.41.3 ± 0.41.5 ± 0.50.0001
 CRP6.1 ± 145.7 ± 136.6 ± 160.6
 Creatinine clearance, mL/min76 ± 3286 ± 3265 ± 29<0.0001
Treatment
 Statins82 (23.1)44 (23.2)38 (23.8)0.9
 ASA146 (41.1)67 (35.3)79 (49.1)0.009
 Antihypertensive treatment196 (55.2)89 (47.6)107 (66.9)0.0003
 B-blocker135 (38.0)57 (30.5)78 (48.8)0.001
 Diuretics61 (17.2)20 (10.8)41 (25.6)0.0003
 ACE inhibitors62 (17.5)37 (19.9)25 (15.6)0.3
 Angiotensin receptor blockers30 (8.5)13 (7.0)17 (10.6)0.2
 Calcium channel blockers56 (15.8)28 (15.1) 28 (17.5)0.5
Door-needle, minutes60 (50–77)60 (51–78)59 (49–77)0.8

Abbreviations: BMI: body mass index; BP: blood pressure; NIHSS: National Institute of Health Stroke Scale; IGT: impaired glucose tolerance; MAP: mean arterial pressure; OGTT: oral glucose tolerance test; OGTT-120 min, 120 minutes post glucose challenge during oral glucose tolerance test; mRS: modified rankin scale; CRP: c reactive protein; LDL: low density lipoprotein; HDL: high density lipoprotein; ASA: acetyl salicylic acid.
Data are described as (%), means ± SD or median with interquartile range in parentheses. Creatinin-clearance is calculated from the Cockroft-Gault formula.